
Donna A. Jagoe
Examiner (ID: 8925)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1619 |
| Total Applications | 644 |
| Issued Applications | 169 |
| Pending Applications | 182 |
| Abandoned Applications | 293 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6982933
[patent_doc_number] => 20050153003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Anti-aging cosmetic composition and method of application'
[patent_app_type] => utility
[patent_app_number] => 11/078030
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1604
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153003.pdf
[firstpage_image] =>[orig_patent_app_number] => 11078030
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/078030 | Anti-aging cosmetic composition and method of application | Mar 10, 2005 | Abandoned |
Array
(
[id] => 7188676
[patent_doc_number] => 20050192341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Non-psychotropic cannabinoids for prevention of cognitive impairment'
[patent_app_type] => utility
[patent_app_number] => 11/073250
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13505
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192341.pdf
[firstpage_image] =>[orig_patent_app_number] => 11073250
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/073250 | Non-psychotropic cannabinoids for prevention of cognitive impairment | Mar 3, 2005 | Abandoned |
Array
(
[id] => 6911879
[patent_doc_number] => 20050175637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Methods for enhancing wound healing'
[patent_app_type] => utility
[patent_app_number] => 11/061299
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4297
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175637.pdf
[firstpage_image] =>[orig_patent_app_number] => 11061299
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/061299 | METHODS FOR ENHANCING WOUND HEALING | Feb 17, 2005 | Abandoned |
Array
(
[id] => 6911879
[patent_doc_number] => 20050175637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Methods for enhancing wound healing'
[patent_app_type] => utility
[patent_app_number] => 11/061299
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4297
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175637.pdf
[firstpage_image] =>[orig_patent_app_number] => 11061299
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/061299 | Methods for enhancing wound healing | Feb 17, 2005 | Abandoned |
Array
(
[id] => 5694801
[patent_doc_number] => 20060154948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Treating allergic and inflammatory conditions'
[patent_app_type] => utility
[patent_app_number] => 11/033919
[patent_app_country] => US
[patent_app_date] => 2005-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4692
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154948.pdf
[firstpage_image] =>[orig_patent_app_number] => 11033919
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/033919 | Treating allergic and inflammatory conditions | Jan 11, 2005 | Abandoned |
Array
(
[id] => 5632367
[patent_doc_number] => 20060148837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction'
[patent_app_type] => utility
[patent_app_number] => 11/028180
[patent_app_country] => US
[patent_app_date] => 2005-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5496
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148837.pdf
[firstpage_image] =>[orig_patent_app_number] => 11028180
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/028180 | Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction | Jan 3, 2005 | Abandoned |
Array
(
[id] => 5766609
[patent_doc_number] => 20060018844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Botulinum toxin dental therapy for angular cheilosis'
[patent_app_type] => utility
[patent_app_number] => 11/029546
[patent_app_country] => US
[patent_app_date] => 2005-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20218
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018844.pdf
[firstpage_image] =>[orig_patent_app_number] => 11029546
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/029546 | Botulinum toxin dental therapy for angular cheilosis | Jan 3, 2005 | Abandoned |
Array
(
[id] => 5135670
[patent_doc_number] => 20070077299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Oral formulation for 5-ht-receptor agonists, uses and methods of treatment employing the same'
[patent_app_type] => utility
[patent_app_number] => 10/577760
[patent_app_country] => US
[patent_app_date] => 2004-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5739
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577760
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577760 | Oral formulation for 5-ht-receptor agonists, uses and methods of treatment employing the same | Oct 31, 2004 | Abandoned |
Array
(
[id] => 7145349
[patent_doc_number] => 20050119194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Methods of using and compositions comprising thalidomide for treatment, modification and management of fibromyalgia'
[patent_app_type] => utility
[patent_app_number] => 10/972311
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10467
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119194.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972311
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972311 | Methods of using and compositions comprising thalidomide for treatment, modification and management of fibromyalgia | Oct 21, 2004 | Abandoned |
Array
(
[id] => 6917727
[patent_doc_number] => 20050095288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Decongestant and expectorant tablets'
[patent_app_type] => utility
[patent_app_number] => 10/970564
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5794
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095288.pdf
[firstpage_image] =>[orig_patent_app_number] => 10970564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/970564 | Decongestant and expectorant tablets | Oct 20, 2004 | Abandoned |
Array
(
[id] => 7117212
[patent_doc_number] => 20050070513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Treatment of inflammatory bowel disease with vitamin D compounds'
[patent_app_type] => utility
[patent_app_number] => 10/969394
[patent_app_country] => US
[patent_app_date] => 2004-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7765
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10969394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/969394 | Treatment of inflammatory bowel disease with vitamin D compounds | Oct 19, 2004 | Abandoned |
Array
(
[id] => 7083909
[patent_doc_number] => 20050049289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Pramipexole for the treatment ADHD'
[patent_app_type] => utility
[patent_app_number] => 10/958156
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1716
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10958156
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/958156 | Pramipexole for the treatment ADHD | Oct 3, 2004 | Abandoned |
Array
(
[id] => 7103543
[patent_doc_number] => 20050106269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Increasing cerebral bioavailability of drugs'
[patent_app_type] => utility
[patent_app_number] => 10/952533
[patent_app_country] => US
[patent_app_date] => 2004-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11665
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106269.pdf
[firstpage_image] =>[orig_patent_app_number] => 10952533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/952533 | Increasing cerebral bioavailability of drugs | Sep 27, 2004 | Abandoned |
Array
(
[id] => 7127994
[patent_doc_number] => 20050059738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion'
[patent_app_type] => utility
[patent_app_number] => 10/948026
[patent_app_country] => US
[patent_app_date] => 2004-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6313
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059738.pdf
[firstpage_image] =>[orig_patent_app_number] => 10948026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/948026 | Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion | Sep 22, 2004 | Abandoned |
Array
(
[id] => 7127962
[patent_doc_number] => 20050059706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Treatment of diabetes with thiazolidinedione and metformin'
[patent_app_type] => utility
[patent_app_number] => 10/947166
[patent_app_country] => US
[patent_app_date] => 2004-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3544
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059706.pdf
[firstpage_image] =>[orig_patent_app_number] => 10947166
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/947166 | Treatment of diabetes with thiazolidinedione and metformin | Sep 22, 2004 | Abandoned |
Array
(
[id] => 6918757
[patent_doc_number] => 20050096318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Pharmaceutically active morpholinol'
[patent_app_type] => utility
[patent_app_number] => 10/944814
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6473
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096318.pdf
[firstpage_image] =>[orig_patent_app_number] => 10944814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/944814 | Pharmaceutically active morpholinol | Sep 20, 2004 | Abandoned |
Array
(
[id] => 7034386
[patent_doc_number] => 20050032896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Use of synthetic retinoic acid in form of 13-cis vitamin A for treatment of autism'
[patent_app_type] => utility
[patent_app_number] => 10/936994
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2310
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10936994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/936994 | Use of synthetic retinoic acid in form of 13-cis vitamin A for treatment of autism | Sep 7, 2004 | Abandoned |
Array
(
[id] => 7209005
[patent_doc_number] => 20050053656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Compositions and methods for treating pain'
[patent_app_type] => utility
[patent_app_number] => 10/932575
[patent_app_country] => US
[patent_app_date] => 2004-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3174
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10932575
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/932575 | Compositions and methods for treating pain | Sep 1, 2004 | Abandoned |
Array
(
[id] => 397682
[patent_doc_number] => 07294651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-13
[patent_title] => 'Inhibition of exoprotein production using isoprenoid compositions'
[patent_app_type] => utility
[patent_app_number] => 10/900251
[patent_app_country] => US
[patent_app_date] => 2004-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8511
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/294/07294651.pdf
[firstpage_image] =>[orig_patent_app_number] => 10900251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/900251 | Inhibition of exoprotein production using isoprenoid compositions | Jul 26, 2004 | Issued |
Array
(
[id] => 7083925
[patent_doc_number] => 20050049305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Use of L-carnitine in the prevention and treatment of hearing loss'
[patent_app_type] => utility
[patent_app_number] => 10/899439
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9282
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049305.pdf
[firstpage_image] =>[orig_patent_app_number] => 10899439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/899439 | Use of L-carnitine in the prevention and treatment of hearing loss | Jul 25, 2004 | Abandoned |